Litigation Details for Amgen Inc. v. Alembic Pharmaceuticals Limited (D. Del. 2021)
✉ Email this page to a colleague
Amgen Inc. v. Alembic Pharmaceuticals Limited (D. Del. 2021)
Docket | ⤷ Try a Trial | Date Filed | 2021-01-19 |
Court | District Court, D. Delaware | Date Terminated | 2021-06-08 |
Cause | 35:1 Patent Infringement | Assigned To | Colm Felix Connolly |
Jury Demand | Defendant | Referred To | |
Patents | 7,361,649; 7,361,650; 7,867,996; 7,879,842 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Amgen Inc. v. Alembic Pharmaceuticals Limited
Details for Amgen Inc. v. Alembic Pharmaceuticals Limited (D. Del. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2021-01-19 | 3 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,361,649 B2; 7,361,650 B2; 7,867,996… 2021 8 June 2021 1:21-cv-00061 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
2021-05-07 | 31 | Notice of Service | Preliminary Invalidity Contentions for U.S. Patent Nos. 7,361,649, 7,361,650, 7,867,996 & 7,879,842 filed … 2021 8 June 2021 1:21-cv-00061 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |